DVM

Dược liệu Việt Nam ·HNX ·2026Q1

▼▼ Declining sharply

Capital efficiency remains weak ROE 2.66%, −1.54pp YoY
Price
7,000
Latest close
03 Jun 2026
P/E 9.31x
P/B 0.42x
EPS 752
BVPS 16,495
ROE 4.3%
ROA 2.1%
Profit Margin 2.8%
Asset Turnover 0.75x
Equity Mult. 2.08x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DVM is losing revenue quickly, though margins have not been hit proportionally yet — profit is at an all-time high. This only holds if margins can continue to resist — if revenue stays weak, margin pressure will build.

TTM REVENUE
VND 1,180bn
−21.6%YoY
NET MARGIN
2.80%
−0.8ppYoY
TTM NET PROFIT
VND 33bn
−38.8%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 49.0 423.0 330.1 378.0 319.8 406.9 456.7 322.5 393.8 528.7 341.7 364.9
Growth -88% +28% -13% +18% -21% -11% +42% -18% -26% +55% -6%
Net Income 0.2 10.0 8.1 14.8 12.3 12.0 18.2 11.6 8.3 5.9 11.2 17.4
Net Margin 0.38% 2.37% 2.45% 3.92% 3.85% 2.94% 3.98% 3.61% 2.10% 1.11% 3.28% 4.76%

Drivers of DVM's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:

Finance costs ↓ 11.6bn
Selling expenses ↓ 5.2bn
Tax ↓ 2.2bn
Gross profit ↓ 38.9bn
Financial income ↓ 3.1bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:

Finance costs ↓ 8.3bn
Administrative expenses ↓ 7.9bn
Tax ↓ 1.6bn
Selling expenses ↓ 1.6bn
Gross profit ↓ 32.1bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 7.5% = 3.6% × 0.94 × 2.22
2026Q1 4.3% = 2.8% × 0.75 × 2.08

ROE fell from 7.5% to 4.3% — all three components weakened, with asset turnover being the main drag.

Net margin: 2.8% -0.8pp Asset turnover: 0.75x -0.19x Leverage: 2.08x -0.14x

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

very positive positive stable watch under pressure

What is driving the margin?

Net margin narrowed to 2.80%, falling 0.8pp. The main pressure comes from Gross margin fell 0.6pp and SG&A / Revenue rose 0.3pp (in addition, Other profit / Revenue rose 0.1pp added support while Net financial result / Revenue fell 0.0pp remained a drag).

The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.

Profitability trend

Net Margin 2.80% −0.8pp
Gross Margin 9.13% −0.6pp
SG&A / Revenue 2.89% +0.3pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

ROIC fell to 2.66%, losing 1.5pp. That translates to 2.66 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 0.9pp and capital turnover fell 0.19x, with invested capital easing slightly by 66bn — pressure came from both operational efficiency and asset efficiency.

Both margin and turnover weakened — this is a broad-based decline, and cyclical versus structural components need to be separated.

Watchpoints

ROIC remains low

ROIC is currently 2.66% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 2.66% −1.5pp
NOPAT Margin 2.93% −0.9pp
Capital Turnover 0.91x −0.19x
Average Invested Capital 1,300.6bn −66.2bn

Balance Sheet

ROIC declined — the balance sheet shows how capital is being deployed. Capital structure is balanced — liabilities at 1.13x equity, net debt at 0.60x equity.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 5.3 days versus the same period last year. The main moves came from DIO fell 6.3 days, DSO rose 29.9 days, and DPO rose 28.9 days.

Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 133.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +29.9 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 128.3 days +29.9 days
Inventory 61.3 days −6.3 days
Payables 55.6 days +28.9 days
Cash Conversion Cycle 133.9 days −5.3 days

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at 0.60x and interest coverage only at 1.20x.

At present, short-term debt accounts for 97.2% of total debt, cash equals 0.8% of debt, and total debt stands at 467.3bn.

Watchpoints

Interest coverage is thin

Interest coverage is 1.20x, leaving limited room to absorb financing costs.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 97.2% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity 0.60x −0.22x
Interest Coverage 1.20x −0.25x
Cash / Debt 0.8% −6.4pp
Short-term Debt / Total Debt 97.2% +1.1pp
CFO / NI 31.01x +29.81x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 1,124.0bn in 2025, against investing cash flow of 80.2bn.

Post-investment cash flow was positive +1,204.1bn. Financing cash flow was negative +1,176.2bn.

CFO / net income was 31.01x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 1,026.5bn +961.6bn
Cash Capex
FCF TTM

Investment Takeaway

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. The brighter spot is earnings conversion is confirmed, with CFO/NI at 31.01x. The next item to monitor is cash generation still needs confirmation. The main risk still sits in capital efficiency remains weak, with ROIC at 2.7%.

Improvement: earnings conversion looks more confirmed, with CFO / net income at 31.01x.

Watchpoint: Cash generation still needs confirmation.

Key risk: Capital efficiency remains weak.

Statement Data

Item 2025 2024 2023 2022
Net Revenue
1,450.9 1,580.0 1,481.7 1,179.0
Cost of Goods Sold
1,311.0 1,439.4 1,323.5 1,013.8
Gross Profit
139.9 140.6 158.2 165.2
Financial Expenses
42.4 47.7 58.9 44.1
Selling Expenses
6.9 11.3 25.7 31.9
General and Administrative Expenses
41.9 28.4 30.8 28.7
Operating Profit
50.1 57.8 49.0 63.4
Profit Before Tax
47.0 55.4 49.5 63.7
Net Income
40.0 47.9 43.2 54.4
Profit Attributable to Parent
40.0 47.9 43.2 54.4
Earnings per Share
921.00 1,119.00 1,211.00 1,648.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.